Amgen Inc. Cedear (AMGND)
BCBA
Closed
Oct 9, 2026
Day's Range
14.2452 wk Range
9.01Overview - AMGND - Amgen Inc. Cedear
Key Statistics
Valuation
Enterprise Value
256.71B
P/E (Trailing)
‪0.32‬
Price / Book
‪18.46‬
EV / EBITDA
‪14.86‬
Profitability
Profit Margin
‪22.95%‬
Operating Margin
‪35.54%‬
Return on Assets
‪8.66%‬
Return on Equity
‪91.47%‬
Ownership
Float
14.97B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.42‬
50-Day Avg
‪13.83‬
200-Day Avg
‪12.22‬
Dividends
Frequency
Quarterly
Peers - AMGND - Amgen Inc. Cedear
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on BCBA.
- AMGNDBCBAAmgen Inc. Cedear+35.63%52-week change0.32P/E (Trailing)‪22.95%‬Profit Margin
- JNJBCBAJohnson & Johnson CEDEAR+38.30%52-week change11.00P/E (Trailing)‪21.48%‬Profit Margin
- GILDBCBAGilead Sciences Inc.+31.12%52-week change4.84P/E (Trailing)‪-10.63%‬Profit Margin
- BMYBCBABristol-Myers Squibb Co.+35.08%52-week change4.90P/E (Trailing)‪18.87%‬Profit Margin
- MRKBCBAMerck & Co., Inc. CEDEAR+51.25%52-week change2.52P/E (Trailing)‪4.76%‬Profit Margin
- LLYBCBAEli Lilly and Company CEDEAR+43.62%52-week change0.19P/E (Trailing)‪33.52%‬Profit Margin
- BIIBBCBABiogen Inc. CEDEAR+43.89%52-week change3.32P/E (Trailing)‪8.32%‬Profit Margin
Profile Summary - AMGND - Amgen Inc. Cedear
About
Amgen Inc. Cedear represents an interest in Amgen Inc., a global biotechnology company specializing in human therapeutics. The company discovers, develops, manufactures, and delivers innovative biological medicines designed to address serious and often chronic diseases across major therapeutic areas, including…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
